|
|
|
18.08.26 - 16:06
|
Trustate Lands Zack Scott as CTO Amid Rapid Expansion Into New Markets (Business Wire)
|
|
|
TAMPA, Fla.--(BUSINESS WIRE)--Trustate, the leading end-to-end estate operations platform for legal and financial professionals, today announced the appointment of Zack Scott as Chief Technology Officer. A seasoned technology leader with deep expertise in AI, data integration, and enterprise-scale systems, Scott joins Trustate at a pivotal moment as the company expands beyond trusts and estates into broader legal and financial markets.
Scott most recently served as Director of Product and Customer Integration at Edgility, where he played a key leadership role in scaling the company's AI-powered healthcare technology platform. He was instrumental in Edgility's successful acquisition by ABOUT Healthcare, a transaction that combined advanced predictive analytics with care orchestration infrastructure to create a powerful, enterprise-grade solution across the patient journey.
Prior to Edgility, Scott held leadership roles at IBM Watson Health, where he led strategic advisory and integration initiatives for ...
|
|
|
18.08.26 - 13:06
|
Abcuro Announces $66 Million Series D Financing to Advance Its First-In-Class Medicine in Development for Inclusion Body Myositis (Business Wire)
|
|
|
Proceeds to support a potentially registrational clinical study in less severe inclusion body myositis (IBM) patients expected to begin in Q4 2026 and report top line results in 2H 2028
Ulviprubart showed a trend toward clinically meaningful slowing of disease progression in patients with less severe IBM in the previous Phase 2/3 MUSCLE study
Series D financing led by New Leaf Venture Partners, joined by Abcuro's existing investors and new investor Rock Springs Capital
NEWTON, Mass.--(BUSINESS WIRE)--Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases through precise modulation of cytotoxic T cells, today announced the closing of a $66 million Series D financing led by current investor New Leaf Venture Partners with participation of existing investors including funds managed by abrdn Inc., Bain Capital Life Sciences, Samsara BioCapital, Redmile Group, Mass General Brigham Ventures, RA Capital Management, Pontifax, Sanofi Ventures, Foresite Ca...
|
|
|
|
|
17.08.26 - 16:00
|
IBM’s Strengths Are The Reason to Buy Today at $234 (24/7 Wall St.)
|
|
|
IBM just posted its worst mainframe quarter in years, a securities fraud inquiry is hanging over management, and the stock sits nearly 20% below its 52-week high. So why are the franchise's most important growth signals pointing in exactly the opposite direction?...
|
|
|
|
|
|
|
|
|
14.08.26 - 15:24
|
Das Nerdquiz rund um den IBM-PC (Heise)
|
|
|
Der IBM PC 5150 ist 45 Jahre alt geworden. Was als billige Antwort auf Apple, Commodore & Co. gedacht war, wurde schnell zum Standard-PC. Dazu ein Quiz....
|
|
|
13.08.26 - 22:39
|
AGAPE-1 Technology Enters Fundraising Agreement with Castle Placement LLC to Raise Up to $8 Million (Business Wire)
|
|
|
SAN JOSE, Calif.--(BUSINESS WIRE)--AGAPE-1 Technology Inc. (“Agape-1”), a Silicon Valley based Artificial Intelligence (AI) company with autonomous security robots and drone prototypes, has engaged Castle Placement LLC, a Wall Street firm, to raise $5–$8 million for the commercialization of Agape-1's AI security robotics.
Agape-1 business operates in both the San Francisco Bay Area and Los Angeles region, to market its proprietary CDDS platform, an autonomous AI security system for surveillance and threat detection supported by its 110 U.S. patents filed, and to build its UAV assembly.
Leveraging on its AI technology, Agape-1 plans to use this capital injection to build its U.S. production for sales, and to position itself becoming a defense subcontractor with its four retired generals as military advisor /mentor.
“We are pleased to work with Castle Placement LLC as we advance Agape-1's growth,” said Howard Ho, PhD (Yale University, and a former IBM leader), Acting CEO. “This capital will ac...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
